Easy does it! New EZH2 inhibitor SHR2554 is safe and active in relapsed or refractory lymphoma

Ryu, Y. K., & Amengual, J. E. (2022). Easy does it! New EZH2 inhibitor SHR2554 is safe and active in relapsed or refractory lymphoma. The Lancet Haematology, 9(7), e463–e465. https://doi.org/10.1016/s2352-3026(22)00169-7
Authors:
Yun Kyoung Ryu
Jennifer E Amengual
Affiliated Authors:
Yun Kyoung Ryu
Jennifer E Amengual
Columbia Affiliation:
Subjects:
Lymphoma (MeSH)
Lymphoma, Non-Hodgkin (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/s2352-3026(22)00169-7
PMID:
35772421
DOI:
10.1016/s2352-3026(22)00169-7
Journal:
Lancet Haematology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: